WHO ICTRP trial

A randomised phase 3 trial of Palliative care Early in Advanced Lung Cancers.

ACTRN12617000166370 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12617000166370
Public title A randomised phase 3 trial of Palliative care Early in Advanced Lung Cancers.
Scientific title Efficacy of early referral to palliative care for improving quality of life and health care resources following recent diagnosis of advanced thoracic maglignancies.
Primary sponsor University of Sydney
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia;New Zealand
Conditions Adults with advanced thoracic malignancy (NSCLC, SCLC or MPM) that have been newly diagnosed within the last 60 days.; Adults with advanced thoracic malignancy (NSCLC, SCLC or MPM) that have been newly diagnosed within the last 60…
Interventions Standard oncological care plus early referral (within 7 days of randomisation) to a hospital-based palliative care service for the specified palliative care intervention (first consultation within 90 days of the diagnosis of advanced lung…
Registration date Jan 31, 2017
Target size 200
Secondary IDs CTC 0145/ALTG 13/008
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations